CSFR ligands (GM-CSF, G-CSF, and M-CSF) have been reported as key regulators of MDSC differentiation, and all of these CSFR ligands were differentially upregulated in the KR158B gliomas (Figure 2A). This evidence concerns the gene CSF2 and central nervous system cancer.